Literature DB >> 7935766

Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding.

R Kurokawa1, J DiRenzo, M Boehm, J Sugarman, B Gloss, M G Rosenfeld, R A Heyman, C K Glass.   

Abstract

Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) regulate transcription by binding to response elements in target genes that generally consist of two direct repeat half-sites of consensus sequence AGGTCA (ref. 1). RAR/RXR heterodimers activate transcription in response to all-trans or 9-cis retinoic acid by binding to direct repeats spaced by five base pairs (DR5 elements), such that RAR occupies the downstream half-site. RXR homodimers activate transcription in response to 9-cis retinoic acid by binding to direct repeats spaced by one base pair (DR1 elements). Although RXR/RAR heterodimers bind to DR1 elements with higher affinity than RXR homodimers, in most contexts they are unable to activate transcription in response to either all-trans or 9-cis retinoic acid. As a result, RARs inhibit RXR-dependent transcription from these sites. We report that the switching of the RAR from an activator to an inhibitor of retinoid-dependent transcription requires that it be bound to the upstream half-site of DR1 elements and that it allosterically block the binding of ligand to the RXR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935766     DOI: 10.1038/371528a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  111 in total

1.  Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.

Authors:  F Rastinejad; T Wagner; Q Zhao; S Khorasanizadeh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  AHR38, a homolog of NGFI-B, inhibits formation of the functional ecdysteroid receptor in the mosquito Aedes aegypti.

Authors:  J Zhu; K Miura; L Chen; A S Raikhel
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex.

Authors:  G B Tremblay; A Tremblay; F Labrie; V Giguère
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

4.  Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.

Authors:  D L Osburn; G Shao; H M Seidel; I G Schulman
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1.

Authors:  Vladimir Ramirez-Carrozzi; Tom Kerppola
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 6.  Alcohol and aldehyde dehydrogenases: retinoid metabolic effects in mouse knockout models.

Authors:  Sandeep Kumar; Lisa L Sandell; Paul A Trainor; Frank Koentgen; Gregg Duester
Journal:  Biochim Biophys Acta       Date:  2011-04-15

Review 7.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

8.  Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA.

Authors:  Igor Orlov; Natacha Rochel; Dino Moras; Bruno P Klaholz
Journal:  EMBO J       Date:  2011-12-16       Impact factor: 11.598

9.  Retinoic acid receptors recognize the mouse genome through binding elements with diverse spacing and topology.

Authors:  Emmanuel Moutier; Tao Ye; Mohamed-Amin Choukrallah; Sylvia Urban; Judit Osz; Amandine Chatagnon; Laurence Delacroix; Diana Langer; Natacha Rochel; Dino Moras; Gerard Benoit; Irwin Davidson
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

10.  DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR.

Authors:  K Shulemovich; D D Dimaculangan; D Katz; M A Lazar
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.